Panbela Therapeutics Faces Sharp Stock Decline Amid Public Offering Announcement
Panbela Therapeutics shares plummeted by 65.5% after announcing a $9 million public offering, while other stocks experienced significant movement during Monday's mid-day session, with Palisade Bio, Inc. and OneMedNet Corporation among the gainers, and SMX (Security Matters) Public Limited Company and Inspire Veterinary Partners, Inc. among the losers.